| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC0936 |
| Trial ID | ChiCTR2100048478 |
| Disease | Liver Cancer |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | An exploratory clinical study on the safety and efficacy of novel GPC3-CAR-T cells in the treatment of hepatocellular carcinoma |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Zhengzhou University |
| Cohort 1 | |||||||
|
|||||||